Pulmonx

Pulmonx LUNG Stock

$2.69   -1.645330%
Add to favorites
Market Cap
$117.15M
LOW - HIGH [24H]
$2.66 - $2.89
VOLUME [24H]
$480.78K
P/E Ratio
0
Earnings per share
-$1.01
ISIN
US7458481014
Price   Prediction

Pulmonx Price Chart

Sorry, that's all we've gotfor now...

Pulmonx (LUNG) stock price today is 2.69 USD on Tech Market Large (-1.65% on the day). Updated .

Pulmonx LUNG Financial and Trading Overview

Pulmonx stock price 2.69 USD
Previous Close 2.74 USD
Open 2.84 USD
Bid 2.04 USD x 200
Ask 3.44 USD x 200
Day's Range 2.66 - 2.89 USD
52 Week Range 1.13 - 3.25 USD
Volume 196.48K USD
Avg. Volume 631.15K USD
Market Cap 118.68M USD
Beta (5Y Monthly) 0.171
PE Ratio (TTM) N/A
EPS (TTM) -1.01 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 4.25 USD

LUNG Valuation Measures

Enterprise Value 122.77M USD
Trailing P/E N/A
Forward P/E -2.9684095
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.3368127
Price/Book (mrq) 3.4713373
Enterprise Value/Revenue 1.383
Enterprise Value/EBITDA -3.187

Trading Information

Pulmonx Stock Price History

Beta (5Y Monthly) 0.171
52-Week Change 98.18%
S&P500 52-Week Change 10.51%
52 Week High 3.25 USD
52 Week Low 1.13 USD
50-Day Moving Average 2.16 USD
200-Day Moving Average 1.72 USD

LUNG Share Statistics

Avg. Volume (3 month) 631.15K USD
Avg. Daily Volume (10-Days) 766.8K USD
Shares Outstanding 43.55M
Float 38.21M
Short Ratio 0.86
% Held by Insiders 4.57%
% Held by Institutions 63.14%
Shares Short 787.51K
Short % of Float 2.13%
Short % of Shares Outstanding 1.80%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -47.93%
Operating Margin (ttm) -44.38%
Gross Margin 77.41%
EBITDA Margin -43.38%

Management Effectiveness

Return on Assets (ttm) -19.82%
Return on Equity (ttm) -90.31%

Income Statement

Revenue (ttm) 88.78M USD
Revenue Per Share (ttm) 2.1 USD
Quarterly Revenue Growth (yoy) 6.20%
Gross Profit (ttm) 68.73M USD
EBITDA -38518000 USD
Net Income Avi to Common (ttm) -42553000 USD
Diluted EPS (ttm) -1.01
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 52.69M USD
Total Cash Per Share (mrq) 1.21 USD
Total Debt (mrq) 56.35M USD
Total Debt/Equity (mrq) 164.75 USD
Current Ratio (mrq) 4.053
Book Value Per Share (mrq) 0.785

Cash Flow Statement

Operating Cash Flow (ttm) -25578000 USD
Levered Free Cash Flow (ttm) -9465500 USD

Profile of Pulmonx

Country United States
State CA
City Redwood City
Address 700 Chesapeake Drive
ZIP 94063
Phone 650 364 0400
Website https://www.pulmonx.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 296

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Q&A For Pulmonx Stock

What is a current LUNG stock price?

Pulmonx LUNG stock price today per share is 2.69 USD.

How to purchase Pulmonx stock?

You can buy LUNG shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pulmonx?

The stock symbol or ticker of Pulmonx is LUNG.

Which industry does the Pulmonx company belong to?

The Pulmonx industry is Medical Devices.

How many shares does Pulmonx have in circulation?

The max supply of Pulmonx shares is 43.55M.

What is Pulmonx Price to Earnings Ratio (PE Ratio)?

Pulmonx PE Ratio is now.

What was Pulmonx earnings per share over the trailing 12 months (TTM)?

Pulmonx EPS is -1.01 USD over the trailing 12 months.

Which sector does the Pulmonx company belong to?

The Pulmonx sector is Healthcare.

Pulmonx LUNG included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24429.89 USD —
+0.42
7.16B USD — 24225.3 USD — 24538.78 USD — — 7.16B USD —
us US Tech Global Select Market Com NQGS US 12034.87 USD —
+0.42
— — 11933.12 USD — 12087.81 USD — — — —
us US Tech Health Care IXHC US 1324.44 USD —
-0.63
— — 1322.85 USD — 1342.46 USD — — — —
$2.2T
Total marketcap
$73.16B
Total volume
BTC 58.13%   •   ETH 10.01%
Dominance
Select currency